Stanford University
Showing 801-850 of 1,639 Results
-
Amanda Almond, MSN, RN, FNP-BC
Affiliate, Central Mgmt-Misc AR
BioAmanda joined the Stanford Neurosurgery team in Santa Cruz in March of 2023. She completed a Bachelors and Masters' degree in Nursing at San Francisco State University, and post masters Nurse Practitioner Certification at SFSU. Amanda is certified through the American Association of Nurse Practitioners and her background is in Urgent Care where she has practiced the last 6 years. Currently, she practices in outpatient neurosurgery and is First Assist in surgery. Her primary interests involve neuro-oncology diseases.
-
Christopher Almond
Professor of Pediatrics (Cardiology)
On Leave from 06/08/2026 To 07/08/2026BioChristopher Almond, MD, MPH is Professor of Pediatrics in the Division of Cardiology at the Stanford University School of Medicine where he is a board-certified pediatric cardiologist at Stanford's Lucile Packard Children's Hospital in Palo Alto, CA. His clinical and research interests are focused on pediatric heart failure, mechanical circulatory support, heart transplantation, and anticoagulation. He completed his training in pediatrics, cardiology, and a senior fellowship in heart failure/transplant at Boston Children's Hospital before before appointment as Assistant Professor of Pediatrics at Harvard Medical School/Boston Children’s Hospital. Dr. Almond completed his MPH at the Harvard School of Public Health with a focus on statistics and epidemiology (study design for rare diseases) followed by a Medical Device Fellowship at the FDA in the Division of Cardiovascular Devices at CDRH. Dr. Almond moved to Stanford in 2014 where he currently serves as professor of pediatrics and directs the clinical research program within Pediatric Advanced Cardiac Therapies (PACT) Program. He also serves as Medical Director of the Children’s Heart Center Anticoagulation Management Program at Stanford (CHAMPS). Dr. Almond has a passion for collaborative research serving as PI for federally-funded multi-center clinical trials including the Berlin Heart ventricular assist device (VAD) FDA Trial that led to its FDA approval in 2011, the TEAMMATE (everolimus for heart transplant) Trial, the TROLLEY (Cardiohelp ECMO/anticoagulation RCT in heart failure) Trial, the NHLBI PumpKIN (Jarvik 2015 LVAD) Trial, and the SPOT BIAS Trial, an FDA-funded trial to understand racial/pigment bias in commercial pulse oximeters.
-
Faith Aloboudi
Ph.D. Student in Neurosciences, admitted Autumn 2024
BioI am a second-year Ph.D. Neurosciences IDP Student co-mentored by Dr. Anish Mitra and Dr. Lisa Giocomo elucidating cognitive function in mesoscale cortical networks. I’m also interested in how biopsychosocial factors, like social determinants of health, impact neuropsychiatric disorders.
-
Juan Alonso
Vance D. and Arlene C. Coffman Professor and the James and Anna Marie Spilker Chair of the Department of Aeronautics and Astronautics
BioProf. Alonso is the founder and director of the Aerospace Design Laboratory (ADL) where he specializes in the development of high-fidelity computational design methodologies to enable the creation of realizable and efficient aerospace systems. Prof. Alonso’s research involves a large number of different manned and unmanned applications including transonic, supersonic, and hypersonic aircraft, helicopters, turbomachinery, and launch and re-entry vehicles. He is the author of over 200 technical publications on the topics of computational aircraft and spacecraft design, multi-disciplinary optimization, fundamental numerical methods, and high-performance parallel computing. Prof. Alonso is keenly interested in the development of an advanced curriculum for the training of future engineers and scientists and has participated actively in course-development activities in both the Aeronautics & Astronautics Department (particularly in the development of coursework for aircraft design, sustainable aviation, and UAS design and operation) and for the Institute for Computational and Mathematical Engineering (ICME) at Stanford University. He was a member of the team that currently holds the world speed record for human powered vehicles over water. A student team led by Prof. Alonso also holds the altitude record for an unmanned electric vehicle under 5 lbs of mass.
-
Roberto Alonso-Mori
Senior Scientist, SLAC National Accelerator Laboratory
BioRoberto Alonso-Mori is a Senior Scientist and Head of the Biological Sciences (BIO) Department at the Linac Coherent Light Source (LCLS) at SLAC National Accelerator Laboratory. The BIO department supports a broad range of structural biology and biochemistry research by enabling high-impact user experiments and developing advanced capabilities for X-ray science at the frontiers of biological discovery. He also serves as the Lead for the Biochemistry and Condensed Phase Chemistry (B&CPC) Group. This group leads experiments focused on ultrafast photochemical dynamics in the condensed phase across multiple LCLS instruments using cutting-edge spectroscopy and scattering techniques. The department and group play key roles in driving scientific innovation through the LCLS Scientific Research and Development (SRD) Division, leading and contributing to the development of new experimental approaches, multimodal capabilities, and emerging applications in ultrafast bioscience and chemistry. He also serves as a Principal Investigator at the Stanford PULSE Institute, where he contributes to interdisciplinary programs advancing ultrafast science and enabling the study and control of dynamical processes in complex systems.
Dr. Roberto Alonso-Mori joined SLAC in 2010 after earning a Bachelor’s degree in Physics from the University of Oviedo (Spain), a Master of Science in Physics from the University of Grenoble (France), and a Ph.D. in Earth Sciences from the University of Camerino (Italy). His graduate research was conducted at the European Synchrotron Radiation Facility (ESRF) in Grenoble, France. He began his SLAC career as a Research Associate supporting both SSRL and LCLS, and has since held various roles leading to his current positions in departmental and scientific leadership. -
Burton Alper
Lecturer
BioBurt has dedicated his entire career to making exceptional communication a competitive advantage. He helps leaders articulate their ideas more effectively through improved content development, storytelling, and presentation techniques.
He serves as a Lecturer and Presentation Coach at Stanford’s Graduate School of Business. There, he helps students on all forms of communication ranging from business writing to oral presentations. As part of Stanford’s IGNITE faculty, Burt works with entrepreneurs in India and China to help them deliver compelling investor pitch presentations. He has worked with senior leaders in Stanford’s Athletic Department and several distinguished faculty members at Stanford’s School of Medicine.
Burt also consults with entrepreneurs, executives and corporate teams outside of Stanford who are preparing for high-stakes and high-profile presentations. His coaching ranges from initial content strategy through delivery coaching and anxiety management.
Prior to his work in the presentation coaching arena, Burt spent 12 years at Catchword Branding, a firm he co-founded in 1998. During his tenure there, he served as the head of strategy and business development. -
Holly Alpine
Affiliate, Ethics In Society
BioHolly Alpine is an environmental leader with more than a decade of experience mobilizing employees and shaping climate advocacy inside the tech sector. She co-founded the Enabled Emissions Campaign, which holds Big Tech companies accountable for using advanced technologies to help fossil fuel companies extract oil and gas more cheaply and efficiently. Before launching this advocacy campaign, Holly co-founded and scaled Microsoft’s global employee sustainability network to 10,000+ members. She also founded the company’s Community Environmental Sustainability program, which established corporate policy for investing in sustainability projects in datacenter communities worldwide. Holly played a central role in strengthening Microsoft’s climate commitments by creating direct channels between employees and senior leadership and elevating climate advocacy as a shared responsibility across the company. She also has served on the boards of American Forests and Zero Waste Washington, and is an accomplished plant-based mountain athlete.
-
Leina Alrabadi
Clinical Associate Professor, Pediatrics - Gastroenterology
BioI enjoy working with a multidisciplinary team to care for patients who have complex medical needs with the aim of giving children a better future. As a clinical researcher, my main focus is on finding improved therapies for autoimmune and cholestatic liver diseases, since an ideal therapy currently does not exist.
-
Burak Alsan, MD
Clinical Assistant Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsPilot Study on the Use of Televisits for Transition Education for Young Adults with Chronic Disease
-
Emily Alsentzer
Assistant Professor of Biomedical Data Science, of Medicine (Computational Medicine) and, by courtesy, of Computer Science
BioDr. Emily Alsentzer is an Assistant Professor in Biomedical Data Science and, by courtesy, Computer Science at Stanford University. Her research leverages machine learning (ML) and natural language processing (NLP) to augment clinical decision-making and broaden access to high quality healthcare. She focuses on integrating medical expertise into ML models to ensure responsible deployment in clinical workflows. Dr. Alsentzer completed a postdoctoral fellowship at Brigham and Women’s Hospital where she worked to deploy ML models within the Mass General Brigham healthcare system. She received her PhD from the Health Sciences and Technology program at MIT and Harvard Medical School and holds degrees in computer science (BS) and biomedical informatics (MS) from Stanford University. She has served as General Chair for the Machine Learning for Health Symposium and founding organizer for SAIL and the Conference on Health, Inference, and Learning (CHIL).
-
Olivia Altamirano, PhD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsCulturally Sensitive Therapy is a group psychotherapy for people with early psychosis and their families. Study aims are to understand if this treatment is compatible with this population, to assess improvements in family functioning and mental health symptoms, to assess mediating factors (e.g., increased usage of adaptive religious and other cultural beliefs/values), and to assess longevity of improvements. Last, we aim to qualitatively understand participants’ experiences with this treatment.
-
Nicolas Altemose
Assistant Professor of Genetics
Current Research and Scholarly InterestsThe Altemose Lab develops new experimental and analytical tools to study how chromatin proteins organize and regulate complex regions of the human genome.
